LISATA THERAPEUTICS, INC. Deferred Tax Assets, Deferred Income
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Assets, Deferred Income of $0 as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2021-02-25
- 2020-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2019-12-31: Deferred Tax Assets, Deferred Income $336.00K.
- 2018-12-31: Deferred Tax Assets, Deferred Income $1.03M.
- 2017-12-31: Deferred Tax Assets, Deferred Income $1.78M.
| Period end | Deferred Tax Assets, Deferred Income | Deferred Tax Assets, Deferred Income as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 | |
| 2019-12-31 | $336.00K 10-K · filed 2021-02-25 | |
| 2018-12-31 | $1.03M 10-K · filed 2020-03-05 | |
| 2017-12-31 | $1.78M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | $1.85M 10-K · filed 2017-03-17 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-17 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 | |
| 2013-12-31 | $23.10K 10-K · filed 2016-03-15 | $10.50K 10-K · filed 2014-03-13 |
| 2012-12-31 | $23.10K 10-K · filed 2015-03-02 | |
| 2011-12-31 | $212.90K 10-K · filed 2013-03-11 | |
| 2010-12-31 | $149.00K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |